Related references
Note: Only part of the references are listed.Antibody-directed coupling of endoglin and MMP-14 is a key mechanism for endoglin shedding and deregulation of TGF-β signaling
S. Kumar et al.
ONCOGENE (2014)
Prognostic and Predictive Blood-Based Biomarkers in Patients with Advanced Pancreatic Cancer: Results from CALGB80303 (Alliance)
Andrew B. Nixon et al.
CLINICAL CANCER RESEARCH (2013)
Deficiency for endoglin in tumor vasculature weakens the endothelial barrier to metastatic dissemination
Charlotte Anderberg et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2013)
Correlation of angiogenic biomarker signatures with clinical outcomes in metastatic colorectal cancer patients receiving capecitabine, oxaliplatin, and bevacizumab
Yingmiao Liu et al.
CANCER MEDICINE (2013)
A Phase I First-in-Human Study of TRC105 (Anti-Endoglin Antibody) in Patients with Advanced Cancer
Lee S. Rosen et al.
CLINICAL CANCER RESEARCH (2012)
Endoglin mediates fibronectin/α5β1 integrin and TGF-β pathway crosstalk in endothelial cells
Hongyu Tian et al.
EMBO JOURNAL (2012)
Prognostic or predictive plasma cytokines and angiogenic factors for patients treated with pazopanib for metastatic renal-cell cancer: a retrospective analysis of phase 2 and phase 3 trials
Hai T. Tran et al.
LANCET ONCOLOGY (2012)
Adhesion-modulating/matricellular ECM protein families: A structural, functional and evolutionary appraisal
Deane F. Mosher et al.
MATRIX BIOLOGY (2012)
Endoglin Requirement for BMP9 Signaling in Endothelial Cells Reveals New Mechanism of Action for Selective Anti-Endoglin Antibodies
Olivier Nolan-Stevaux et al.
PLOS ONE (2012)
Matricellular Proteins: A Sticky Affair with Cancers
Han Chung Chong et al.
JOURNAL OF ONCOLOGY (2012)
The role of pericytes in angiogenesis
Domenico Ribatti et al.
INTERNATIONAL JOURNAL OF DEVELOPMENTAL BIOLOGY (2011)
Biomarkers in Tumor Angiogenesis and Anti-Angiogenic Therapy
Andreas Pircher et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2011)
Soluble Endoglin Specifically Binds Bone Morphogenetic Proteins 9 and 10 via Its Orphan Domain, Inhibits Blood Vessel Formation, and Suppresses Tumor Growth
Roselyne Castonguay et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2011)
Biomarkers of Anti-Angiogenic Therapy in Metastatic Colorectal Cancer (mCRC): Original Data and Review of the Literature
M. Pohl et al.
ZEITSCHRIFT FUR GASTROENTEROLOGIE (2011)
Biomarkers of angiogenesis and their role in the development of VEGF inhibitors
N. Murukesh et al.
BRITISH JOURNAL OF CANCER (2010)
Matrix Metalloproteinase-14 (MT1-MMP)-Mediated Endoglin Shedding Inhibits Tumor Angiogenesis
Lukas J. A. C. Hawinkels et al.
CANCER RESEARCH (2010)
Targeting cancer vasculature via endoglin/CD105: a novel antibody-based diagnostic and therapeutic strategy in solid tumours
Ester Fonsatti et al.
CARDIOVASCULAR RESEARCH (2010)
Control of vascular morphogenesis and homeostasis through the angiopoietin-Tie system
Hellmut G. Augustin et al.
NATURE REVIEWS MOLECULAR CELL BIOLOGY (2009)
VEGF-A Stimulates ADAM17-Dependent Shedding of VEGFR2 and Crosstalk Between VEGFR2 and ERK Signaling
Steven Swendeman et al.
CIRCULATION RESEARCH (2008)
The TGF beta pathway as a therapeutic target in cancer
Joan Seoane
CLINICAL & TRANSLATIONAL ONCOLOGY (2008)
Anti-tumor activity of an anti-endoglin monoclonal antibody is enhanced in immunocompetent mice
Masanori Tsujie et al.
INTERNATIONAL JOURNAL OF CANCER (2008)
Antiangiogenic chimeric anti-endoglin (CD105) antibody: pharmacokinetics and immunogenicity in nonhuman primates and effects of doxorubicin
K Shiozaki et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2006)
Regional effects of an antivascular endothelial growth factor receptor monoclonal antibody on receptor phosphorylation and apoptosis in human 253J B-V bladder cancer xenografts
DW Davis et al.
CANCER RESEARCH (2004)
Endoglin promotes endothelial cell proliferation and TGF-β/ALK1 signal transduction
F Lebrin et al.
EMBO JOURNAL (2004)
Balancing the activation state of the endothelium via two distinct TGF-β type I receptors
MJ Goumans et al.
EMBO JOURNAL (2002)
Share Paper
